ArticleFoods (Basel, Switzerland)2026
Anthocyanin-Rich Pigment Supplements in the Australian Online Market: Sources, Labelling Practices, and Bioactivity Claims.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amid growing consumer interest in the health benefits of anthocyanins, the market for anthocyanin-based dietary supplements has expanded substantially. However, data on product composition and health claims in the Australian online market remains limited. This study characterises anthocyanin-based dietary supplements available online in Australia (July-August 2024), examining product origin, botanical sources, formulation, extract concentration, delivery formats, anthocyanin content disclosure, health claims, serving sizes and pricing patterns. Among the 121 products analysed, bilberry, elderberry, and tart cherry were the most commonly used anthocyanin sources, collectively representing 47% of the market. Capsules were the dominant delivery format (86%), and reported extract concentrations varied widely, with lower ratios (1-10:1) being most prevalent. Only 18% of products disclosed anthocyanin content (0.1-36%), with bilberry supplements accounting for the majority of reported values. Health claims were present on 69% of products and varied by source, with bilberry products most frequently promoting vision health, elderberry emphasising immune support, tart cherry targeting joint and exercise recovery, and cranberry focusing on urinary tract health. Declared extract (mg per serving) ranged from 10 mg to >1500 mg. Pricing varied substantially across products (AUD 0.02-7.40 per gram; mean AUD 0.78/g), with bilberry supplements consistently among the most expensive. Overall, these findings highlight considerable variability in formulation, disclosure, and health claim practices, underscoring the need for improved transparency and evidence-aligned representation of anthocyanins as bioactive pigments in the Australian nutraceutical market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.